Professor of Urology
University of california Los Angeles, United States
Dr. Reiter is Professor and Chief of Urologic Oncology at UCLA School of Medicine. He is also Assistant Dean for Innovation and Entrepreneurship. Dr Reiter's clinical focus is on prostate cancer, where he has been an innovator and leader in robotic surgery and molecular and anatomic imaging. His laboratory has published extensively on the identification and translation of novel cell surface proteins for treatment and imaging of prostate cancer, including the discovery of Prostate Stem Cell Antigen. He has been Principal Investigator of UCLA's Prostate Cancer SPORE since 2001, a multi-million dollar multidisplinary program project grant focused on translational science in prostate cancer, a program that has led to the discovery of agents such as enzalutamide and apalutamide. He has also been a serial entrepreneur, having co-founded Agensys, EMTx Therapeutics, and ImaginAb.
SYMP-01: PSMA-Targeted Radioligand Therapy in Taxan-Naive mCRPC Patients?
Wednesday, October 29, 2025
16:45 - 17:00 GMT+0
SYMP-03: Oncologic Outcome of PSMA Radio-guided Surgery in Prostate Cancer
Wednesday, October 29, 2025
10:13 - 10:21 GMT+0
Wednesday, October 29, 2025
10:37 - 10:49 GMT+0
Thursday, October 30, 2025
12:45 - 14:00 GMT+0
SS-02: Welcome and Session Introductions
Thursday, October 30, 2025
12:45 - 12:50 GMT+0
HT-03: Molecular Markers & PSMA Expression
Thursday, October 30, 2025
14:48 - 15:00 GMT+0